BRCA1 and breast carcinoma: The presented data can confirm a noticeable contribution of BRCA1 5382insC mutation in breast cancer development in Ukraine and as there is no difference between the frequency of mutations in the groups with and without a FH it may justify to screen for 5382insC mutation all breast cancer patients totally, not primarily that who have a FH.